[Results of a cyclophosphamide therapy in genital and mammary carcinomas].
D000328:Adult; D000505:Alopecia / Q000139:chemically induced; D001859:Bone Neoplasms / Q000188:drug therapy*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D002277:Carcinoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D003864:Depression, Chemical; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D013739:Testosterone / Q000627:therapeutic use*
D013739:Testosterone; D003520:Cyclophosphamide
Ergebnisse mit der Zyklophosphamidbehandlung bei Genital- und Mammakarzinomen.